Evidence map›Paper›PMID 36656322›Full record

ArticleApplied microbiology and biotechnology2023

Thermostable negative-marker foot-and-mouth disease virus serotype O induces protective immunity in guinea pigs.

Huildore Bommanna Ranjitha, Valiya Valappil Dhanesh, Madhusudan Hosamani, B P Sreenivasa, Uzma Jabeen, Jitendra Kumar Biswal, P Saravanan, Aniket Sanyal, Veerakyathappa Bhanuprakash, Suresh H Basagoudanavar

Open access · bronzeAbstract read
In one paragraph

Article in Applied microbiology and biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Huildore Bommanna RanjithaFMD Vaccine Research Laboratory, ICAR-Indian Veterinary Research Institute, Hebbal, Bengaluru, 560 024, India.
Valiya Valappil DhaneshFMD Vaccine Research Laboratory, ICAR-Indian Veterinary Research Institute, Hebbal, Bengaluru, 560 024, India.
Madhusudan HosamaniFMD Vaccine Research Laboratory, ICAR-Indian Veterinary Research Institute, Hebbal, Bengaluru, 560 024, India.
B P SreenivasaFMD Vaccine Research Laboratory, ICAR-Indian Veterinary Research Institute, Hebbal, Bengaluru, 560 024, India.
Uzma JabeenFMD Vaccine Research Laboratory, ICAR-Indian Veterinary Research Institute, Hebbal, Bengaluru, 560 024, India.
Jitendra Kumar BiswalDirectorate of Foot and Mouth Disease, ICAR-International Centre for FMD, Bhubaneswar, 752 050, India.
P SaravananFMD Vaccine Research Laboratory, ICAR-Indian Veterinary Research Institute, Hebbal, Bengaluru, 560 024, India.
Aniket SanyalFMD Vaccine Research Laboratory, ICAR-Indian Veterinary Research Institute, Hebbal, Bengaluru, 560 024, India.
Veerakyathappa BhanuprakashFMD Vaccine Research Laboratory, ICAR-Indian Veterinary Research Institute, Hebbal, Bengaluru, 560 024, India.
Suresh H BasagoudanavarFMD Vaccine Research Laboratory, ICAR-Indian Veterinary Research Institute, Hebbal, Bengaluru, 560 024, India. basagoudanavar.sh@icar.gov.in.ORCID http://orcid.org/0000-0001-7714-3120
Indian Veterinary Research Institute · INProject Directorate on Foot and Mouth Disease · IN

Funding

ICAR-Indian Veterinary Research Institute CAAST/ACLH/NAHEP/2018-19
6 · The paper itself

Abstract

Foot-and-mouth disease (FMD) is a contagious viral disease of high economic importance, caused by FMD virus (FMDV), a positive-sense single-stranded RNA virus, affecting cloven-hoofed animals. Preventive vaccination using inactivated virus is in practice to control the disease in many endemic countries. While the vaccination induces antibodies mainly to structural proteins, the presence of antibodies to the non-structural proteins (NSP) is suggestive of infection, a criterion for differentiation of infected from vaccinated animals (DIVA). Also, there is a growing demand for enhancing the stability of the FMD vaccine virus capsid antigen as the strength of the immune response is proportional to the amount of intact 146S particles in the vaccine. Considering the need for a DIVA compliant stable vaccine, here we report generation and rescue of a thermostable and negative marker virus FMDV serotype O (IND/R2/1975) containing a partial deletion in non-structural protein 3A, generated by reverse genetics approach. Immunization of guinea pigs with the inactivated thermostable-negative marker virus antigen induced 91% protective immune response. Additionally, a companion competitive ELISA (cELISA) targeting the deleted 3A region was developed, which showed 92.3% sensitivity and 97% specificity, at cut-off value of 36% percent inhibition. The novel thermostable-negative marker FMDV serotype O vaccine strain and the companion cELISA could be useful in FMDV serotype O enzootic countries to benefit the FMD control program. KEY POINTS: • Thermostable foot-and-mouth disease virus serotype O with partial deletion in 3A. • Inactivated thermostable marker vaccine induced 91% protection in guinea pigs. • Companion cELISA based on deleted region in 3A could potentially facilitate DIVA.

Indexed as

Foot-and-Mouth DiseaseFoot-and-Mouth Disease VirusViral VaccinesAnimalsAntibodies, ViralAntigens, ViralGuinea PigsSerogroupAntibodies, ViralAntigens, ViralViral VaccinesCompetitive ELISADifferentiation of infected from vaccinated animalsFoot-and-mouth diseaseThermostable negative-markerVaccine

Identifiers

PMID36656322
PMCPMC9850340
OpenAlexW4317434613

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.